甘李药业：旭特宏达拟减持0.57%公司股份

Core Viewpoint - Ganli Pharmaceutical (603087) announced that Xutong Hongda and its concerted actor Gan Zhongru collectively hold 40.11% of the company's shares, with Xutong Hongda holding 5.90% [1] Shareholding and Reduction Plans - Xutong Hongda plans to reduce its holdings by no more than 3,399,500 shares, accounting for 0.57% of the total share capital, within three months after 15 trading days from the announcement date [1] - Jiao Jiao intends to reduce no more than 67,500 shares, representing 0.0112% of the total share capital [1] - Sun Cheng plans to reduce no more than 20,000 shares, which is 0.0033% of the total share capital [1] Impact on Company Governance - The reduction plans will not affect the company's governance structure or its ongoing operations [1]